[1]
H. Fujimoto and J. Kiryu, “Efficacy of the Rho-kinase Inhibitor Ripasudil for Fuchs’ Endothelial Corneal Dystrophy”, jor, vol. 4, no. 3, pp. 231–243, Aug. 2021.